The vaccine’s first public administration – we look at the main issues surrounding the introduction.
With the first use of Oxford/Covid AstraZeneca’s vaccine, the biggest vaccination campaign in the history of the United Kingdom will receive a huge boost on Monday. Here, we are looking at some key questions about the vaccine’s launch in England.
On Monday, will I get my first vaccination?
No matter how noisy the fanfare surrounding the Oxford/AstraZeneca vaccine’s launch, every new vaccine is deployed carefully. The effectiveness of this vaccine should not be overestimated because it is kept at normal temperatures in the refrigerator and can be taken out and delivered to nursing homes and anywhere else very quickly.
The first doses, however, would only be administered “for surveillance purposes,” in a few hospitals, according to NHS England. That’s only in case there are malfunctions, such as the allergy issue that occurred when the NHS started using the vaccine from Pfizer/BioNTech. That has now been addressed, by the way, with the instruction that individuals with an allergy background are OK unless they are directly allergic to one of the ingredients in one of the vaccines.
Photo ops on Monday are likely to take place in Oxford hospitals, as the vaccine was developed by the university.
But the Royal Free Hospital NHS Foundation Trust in London, Guy’s and St Thomas’, University Hospitals of Morecambe Bay, Brighton and Sussex and George Eliot Hospital NHS Trust will also begin vaccination on Monday. They will then be delivered to doctor-led vaccination centers around the country later in the week. In England, there are currently 700 of these centers; this week, NHS England said, another 180, plus 100 more hospitals, will begin vaccinating.
As a priority, who should be given the Oxford/AstraZeneca vaccination?
Residents in nursing homes and the workers who care for them, as they have been, are at the top of the list.
But it was difficult because it is not easy to store and transport the Pfizer vaccine, requiring prolonged storage at -70 ° C. The emphasis could be on this community this time. By the end of January, GPs are being given £ 10 for each care home resident they can vaccinate.
Who has so far been vaccinated?
In comparison to the comments of politicians, official statistics from NHS England indicate that in the first three weeks after the Pfizer vaccine was introduced in England, around 750,000 people were vaccinated, including 524,439 over 80. The second priority group is the over-80s and NHS staff.
Ministers say a vaccine has been given to around 1 million people.
Now that we have the Oxford vaccine, can things accelerate?
Hopefully, yes, but it would take the whole year to get those most at risk through the pace of a quarter of a million people being vaccinated every week in England – practically everybody over 50 and those with underlying health issues. Matt Hancock, the minister of health, says he’s aiming for 2 million a week in the UK. Briefly, and counting.
Delays can also occur. For 4 million individuals, there is enough of the Oxford/AstraZeneca vaccine, but most of it is not yet in vials in its finished form, nor is it all batch-certified as required by the UK. Interim emergency approval from the regulator. There are just 530,000 doses ready to go into the pockets of people around the U.K. Monday, on.
Why is the second dose delayed and is it going to put individuals at risk?
This is pragmatism about public health. The aim is to minimize as quickly as possible the number of people exposed to infection, which decreases the population’s amount of virus and allows certain restrictions to be removed faster. That’s because after the first dose, both vaccines reach high efficacy – over 80% for Pfizer’s vaccine and 70% for AstraZeneca’s.
There appears to be proof in the case of AstraZeneca that security lasts up to 12 weeks and even beyond. The object of the second vaccination is not to increase this protection, but to keep it longer. There is no publicly available evidence for Pfizer’s vaccine that safety lasts past three weeks since all participants in the study received their second dose at that time.
People who receive a delayed second dose of Pfizer vaccine will not be covered by 95%, but they will still experience a high degree of protection if the government is right,